Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 25, 2023

BUY
$25.15 - $32.86 $1.24 Million - $1.62 Million
49,211 Added 70.38%
119,135 $3.86 Million
Q2 2023

Aug 14, 2023

BUY
$25.15 - $32.86 $1.24 Million - $1.62 Million
49,211 Added 70.38%
119,135 $3.86 Million
Q1 2023

Sep 25, 2023

SELL
$17.5 - $25.9 $861,192 - $1.27 Million
-49,211 Reduced 41.31%
69,924 $1.81 Million
Q1 2023

May 15, 2023

SELL
$17.5 - $25.9 $2.98 Million - $4.41 Million
-170,425 Reduced 70.91%
69,924 $1.81 Million
Q4 2022

Feb 14, 2023

BUY
$13.95 - $19.28 $3.35 Million - $4.63 Million
240,349 New
240,349 $4.32 Million
Q4 2021

Feb 14, 2022

SELL
$21.65 - $27.0 $861,301 - $1.07 Million
-39,783 Reduced 26.52%
110,217 $2.47 Million
Q3 2021

Nov 16, 2021

BUY
$19.51 - $28.7 $2.93 Million - $4.31 Million
150,000 New
150,000 $3.8 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.